1. What can Transfer Factor do for you?
2 BOOSTS
Natural
Killer Cells
or NK cells
are part of
the immune
system.
It’s Primary
responsibilit
y is to seek
and destroy
cancer cells.
A Weak immune system can lead to chronic ailments, infections,
degenerative diseases, and cancer.
2. Evidence from Clinical Studies
7 years Scientific Study on 196 products
TEST RESULTS PUBLISHED IN JANA (Journal of American Nutraceutical Association)
TOP 12 PRODUCTS
1 TRANSFER FACTOR ADV
Immune (NK Cell) Activity
Transfer Factor is
PLUS™ ...437%
2 TRANSFER FACTOR ADV™ ….…... 900% MORE 437%
3.
283%
MANGOSTEEN ….…………………. 76% POWERFUL
than any other
4. IP-6 ……………………………………. 49%
supplement known to
5. PLANT POLYSACCHARIDES…….....48% science! 283%
6. ECHINACEA ………………………… 43%
7. SHITAKE MUSHROOM ………………42%
8. CORDYCEPS FORMULA…………… 28%
9. BOVINE COLOSTRUM/ IgG ............23%
10. PHYTONUTRIENT FORMULA ….. 21% 43%
15% 23%
15%
11. ALOE VERA (Acemannan) …….......15%
12. NONI (Morinda Citrifolia) …..……. 15%
rin i
da)
(Mo Non
4Life 4Life
ea
a
m
Transfer Transfer
Ve r
tru
na c
Factor Factor
lo s
Aloe
Advanced Plus
i
Ech
Co
Source: Jeunesse Inc. - Institute of Longevity Medicine, California, USA
3. Evidence from Clinical Studies
Blokhin Russian Oncology Research Center, Russian Academy of Medical Sciences
Transfer Factors effect the
activation of NK Cells
Similar to the Lymphokine
Interleukin-2
IL2 are artificially activated NK
cells used in cancer therapy
Cost $US5000 per Rx or
$US10,000 per month plus in
hospital and doctor fees.
(US$60,000 for 6 mths)
IL2 side effects listed as:
‘Adverse’ or ‘Life Threatening’
Dr. Kisielevsky of the Russian Academy of Medical
Sciences stated, "The 4Life sample [Transfer Factor
Advanced Formula] activated NK (natural killer) cell
activity more than the Interleukin-2 (IL2) drug used as
the standard. This discovery has attracted the
attention of The International Scientific and Technical
Center (ISTC) of Russia.
4.
5. Evidence from Clinical Studies
7 years Scientific Study on 196 products
TEST RESULTS PUBLISHED IN JANA (Journal of American Nutraceutical Association)
In the function of PREVENTING & OVERCOMING
Diseases, TRANSFER FACTOR is…
8 TIMES MORE EFFECTIVE THAN LINGZHI / GANO
10 TIMES MORE EFFECTIVE THAN ECHINACEA
15 TIMES MORE EFFECTIVE THAN CORDYCEPS
19 TIMES MORE EFFECTIVE THAN COLOSTRUM / IgG
29 TIMES MORE EFFECTIVE THAN NONI & ALOE VERA
30 TIMES MORE EFFECTIVE THAN SPIRULINA, SEA-
CUCUMBER, GINSENG, MACA, ROYAL-JELLY, CHLORELLA,
ALFALFA, GINKGO, GREEN TEA, WHEAT-GRASS,
CHLOROPHYLL, GOTU-KOLA, BEE-PROPOLIS, GRAPE
SEED,….. & MANY OTHERS!
Source: Jeunesse Inc. - Institute of Longevity Medicine, California, USA
7. Evidence from Clinical Studies
SCIENTISTS CALL IT “MIRACLE MOLECULE”
Clinical Validation produced
by the Ministry of Health
Russian Federation
FIRST TIME IN HISTORY:
Nutritional Supplement gets Approval by
Health Ministry of Russia for use in
All Hospitals & Clinics (31 July 04) 7
9. What can Transfer Factor do for you?
1
Educates
Recognize – Internal and external causes of
disease. Respond – contains immunity codes to
help immune system defeat threats by killing them.
Remember – memory molecules help them
remember pathogens when they come back.
Recognize
Remember Respond
11. Third function of Transfer Factor is Regulating
or Balancing your Immune System
OVER REACTION
AUTO IMMUNE ALLERGIC
DISEASES Transfer REACTION
(Hay fever, eczema,
(Type 1 diabetes, rheumatoid Factor asthma, sinusitis)
arthritis, psoriasis, multiple
sclerosis, lupus Scleroderma,
inflammatory bowel disease)
It balances the immune system!
CANCER INFECTION
(Chronic fatigue, (From viruses, bacteria, fungi
hepatitis, HIV, and parasites)
shingles, tuberculosis) Transfer
Factor
UNDER REACTION
12. Transfer Factors are Compliant w/ Standards
No Contra-indication No Overdose No Side Effects
US FDA
Phil FDA
Halal
.R. A.S
G
12
13. Evidence Based Clinical Studies
LEVEL 1 CATEGORY A PHASE 3: INTERNATIONAL STUDIES
AMAZING RESULTS
Level I Category A Phase III
W/ HEPATITIS B
March 1999, Monterrey, Nuevo Leon
25 YEARS OF
CLINICAL
EXPERIENCE WITH
TRANSFER FACTORS
1,647 PATIENTS
A STATISTICALLY
SIGNIFICANT
INCREASE OF
SURVIVAL
back 13
14. What Doctors & Scientists Say About TF
"There is NO OTHER PRODUCT in a nutritional
substance, NOR a drug, that has THIS KIND OF POWER
and ability to affect our immune system. With the increase
of killer viruses, mutated germs, super-resistant germs,
and food contaminations, our only hope and defense, must
lie within our own immune system." -- Darryl See, MD
Associate Clinical Professor W.H.O. ( World Health Organization)
Western Europe, Dr. See received his degree from the University of
California, Irvine. Academic appointments include: Assistant/Associate
Clinical Professor of Medicine: Investigator, California Collaborative
Treatment Group: and Infectious Disease Consultant, Liver
Transplantation Service. He has received contracts, grants, and
research awards from Harvard Biotechnology, Pfizer Pharmaceuticals,
Darryl See M.D. Upjohn Pharmaceuticals, Roche Molecular Systems,, National Institutes
of Health, Department of Defense, and more.
15. Evidence Based Clinical Studies
LEVEL 3 CATEGORY A PHASE III
Conducted by Doctors On Stage 4 cancer patients
Start prognosis: Patients had 3.7 months to live.
Results after six months: 16 out of the 20 patients studied are in remission,
either improving or in stable condition.
Level 3 Category A Phase III
16. Evidence Based Clinical Studies
LEVEL 3 CATEGORY A PHASE 3:
Level 3 Category A Phase III
Mary Anne Myers, aged 45, has diabetes and was on 500mg of
Glucophage. She started taking 8 Transfer Factors per day and
sprinkling 2 capsules directly on the wound for one week. She’s
now taking 6 capsules per day and continue sprinkling Transfer
Factor on the wound. Here are the remarkable results in just
LESS THAN 4 WEEKS .
17. Evidence Based Clinical Studies
LEVEL 3 CATEGORY A PHASE 3:
RONALD, SEVERE
INDONESIA
INFECTION
11 Dec 06
7 Jan 07 20 Jan 07
Ronald, 28 years, met an accident with four of his fingers.
Due to infection, doctors advised amputation to control complications.
Fortunately, another Doctor (Dr. Eduard) a TF Advocate, recommended 6
Capsule of TF Plus & 2 to add on the wound.
Within just 3 days, doctors were shocked as not to see any sign of infection on
his fingers - thereby immediately retracting the earlier decision to amputate.
In just within 6 weeks, his fingers were back to normal.
18. His latest “discovery” is a
product called Transfer
Factor, sourced from colostrum
found in mothers’ and cows’ milk, eggs,
and chickens. According to Fernandez,
Transfer Factor contains the
information molecule that educates the
immune system.
“With Transfer Factor,”
he points out, “a
person’s immune
system is able to correct
itself.”
He cites the case of his
L-R: Dr. Ricardo Fernandez with Dr. Elizabeth Ifurung, US
mother, now 90, whose heart
and body were strengthened by
Ambassador Harry Thomas, Dr. J. Ongsiako, and Cherry Miguel
CoQ10 and who was able to
Dr. Ricardo Fernandez, MD, Chairman regain her vitality after
of Makati Medical Center’s Department taking Transfer Factor.
of Otonrhinolaryngology (ear, nose, and “Now, believe it or not,
throat) comes from a family of doctors. His father, she is back to her old
the late Dr. Manuel C. Fernandez, was one of the
founders of MMC and a brother, Manuel Jr., specializes in self!”- Phil. Star, July 31, 2012 by Alice
cosmetic surgery at the same hospital. Reyes, Health & Family Section
19. DR. LUDGERIO
TORRES
•Cardiologist & Cardiac
Surgeon
•Former Director,
Philippine Heart Center
For 13 Years
•Clinic Hours: Mon –
Fri 6-8pm Rm400
(Except Thu)
•UST Professor
•Former TOYM
•Magna Cum Laude,
Graduate of UST
L-R: Dr. Ricardo Fernandez with Dr. Elizabeth Ifurung, US
Ambassador Harry Thomas, Dr. J. Ongsiako, and Cherry Miguel
Medicine
•Trained at Harvard
University Medical
School, USA
•Independent
Distributor, 4Life
Research Phil LLC
(whole family)
20. “Two patients of mine who had symptoms of heart
attack showed blocked coronary arteries on
coronary angiogram. After giving TF Tri-Factor at
2cap 3x a day for 3 months, the patients decided to
undergo angioplasty. During the angioplasty, there
was clearing of blockage of one vessel so instead of
having 2 stents, only one stent was used. If
prolonged intake was done, probably no need to do
angioplasty.” - DR. LUDGERIO TORRES
21. Evidence Based Clinical Studies
LEVEL 1 CATEGORY A PHASE 3: LOCAL STUDIES
Mon, pabili
AMAZING RESULTS WITH LEPROSY: RESOLVED IN 3 MONTHS
MA. Luisa Venida MD, Dermatologist
ng Magic
PRESIDENT, SKIN RESEARCH FOUNDATION OF THE
PHILIPPINES’ MOST OUTSTANDING PHYSICIAN, 2003 PMA
Awardee
1ST TO STUDY 100% RESOLUTION FOR LEPROSY WITH
TRANSFER FACTOR as ADJUVANT THERAPY
NEW DOSAGING: 8,6,5,4,3,2 DAILY EVERY 2 WEEKS
Level I Category A Phase III
22.
23.
24.
25.
26.
27.
28.
29.
30. Evidence Based Clinical Studies
LEVEL 1 CATEGORY A PHASE 3:
AMAZING RESULTS WITH LEPROSY: RESOLVED IN 3 MONTHS
Level I Category A Phase III
31. Evidence Based Clinical Studies
LEVEL 1 CATEGORY A PHASE 3:
AMAZING RESULTS WITH LEPROSY: RESOLVED IN 3 MONTHS
Level I Category A Phase III
32. Dx. Churg Straus Syndrome
• Severe Asthma
• Severe Vasculitis
Tx.
Transfer Factor Tri-Factor 6 cap/day
Discharged from hospital in 3 days
Clear finger in 2 weeks
32
33. WHAT DOCTORS SAY ABOUT TF
Killer
T-Cells
JAMES MARTINEZ, M.D., INTERNIST
Member, American Society of Hypertension and Philippine US AID Scholar- UVA University of Virginia, Charlottesville
Society of Hypertension Virginia, USA Howard University, Washington D.C. USA
American Diabetes Association and Philippine Diabetes University of Arkansas for Medical Sciences, Arkansas USA
Association
American Medical Informatics Association Private Medical Practitioner: EL ROI MEDICAL CLINIC
American Academy of Family Physicians
AND DIAGNOSTIC CENTER Inc. Kamuning Quezon City
34. Evidence Based Clinical Studies
LEVEL 1 CATEGORY A PHASE 3: LOCAL STUDIES
AMAZING RESULTS WITH HEPATITIS B
VS. NO CURE FROM WESTERN MEDICINE
Left Photo: Woman suffering from Liver Cancer caused by Hepatitis B.
(Courtesy of Patricia Walker, MD, Ramsey Clinic Associates, St. Paul, MN)
Above Photo: "Section of liver damaged by HBV.
Note the enlarged cells & blistering of the capsular surface."
http://www.vaccineinformation.org/photos/hepbuta002.jpg
Copyright, Anthony Demetris, MD Director, Division of
Transplantation Pathology, University of Pittsburgh Medical Center
back 34
35.
36.
37.
38.
39. Antibodies
Surface
Antigen for
Hepa B now
REACTIVE,
thus
Hepa B
NEGATIVE
In just
2 Months,
the first
recorded
labtest
In the Phil.
Note: Now
more than 10
successful
cases &
counting!
40.
41. Evidence Based Clinical Studies
LEVEL 1 CATEGORY A PHASE 3: LOCAL STUDIES
AMAZING RESULTS WITH HEPA B: RESOLVED IN 3 MONTHS
TRIPLE BENEFITS: TF & INTERFERON REGIMEN
SAVINGS: 80% (From P480,000/48 weeks to P97,070/8 weeks only). Save P382,930.
SPEED: Treatment duration cut from 1 year to only 2 months.
SAFETY: Side effects of Interferon reduced if not eliminated.
STANDARD TREATMENT (ST) WITHOUT TF
(48-week Interferon alpha 2a or 2b)
Interferon 2 vials of 3 MIU*/week x P5,000/vial or
P10,000/week x 48 weeks = P480,000
TF & STANDARD TREATMENT COMBINATION
(8 weeks only)
TF 6 cap/day x 60 days = 360 caps or
6 bottles@P2,845 = P17,070
Interferon 2 vials of 3 MIU*/week x P5,000/vial or
P10,000/week x 8 weeks = P80,000
TOTAL COST P97,070
SAVINGS P382,930
SAVINGS = 80%
*MIU=Million International Units, Roche
back 41
42. home
Evidence Based Clinical Studies
MORE & MORE DOCTORS ARE BECOMING ADVOCATES
A skeptic before
DR. ALEX L.Tan, MD, FPCS,
FPSGSSurgical Oncologist
But now a believer! 42
43. Evidence Based Clinical Studies
MORE & MORE DOCTORS ARE BECOMING ADVOCATES
RECURRING POST MASTECTOMY BREAST CANCER
RIGHT BREAST AREA
RECOMMENDED DOSAGE:
6 DAYS OF 15 CAPSULES TF PLUS / DAY
BEFORE
44. Evidence Based Clinical Studies
MORE & MORE DOCTORS ARE BECOMING ADVOCATES
RECURRING POST MASTECTOMY BREAST CANCER
RIGHT BREAST AREA
AFTER
45. Evidence Based Clinical Studies
MORE & MORE DOCTORS ARE BECOMING ADVOCATES
RECURRING POST MASTECTOMY BREAST CANCER
RIGHT BREAST AREA
Before TF Treatment After TF Treatment
46. Evidence Based Clinical Studies
MORE & MORE DOCTORS ARE BECOMING ADVOCATES
A skeptic for 3 years
DR. CATHERINE MENDOZA
PEDIATRICIAN
But now a believer! 46
47. TESTIMONY ON PRIMARY COMPLEX
This is a multi drug resistant TB case (MDRTB)
treated with Triple Anti-Koch’s regimen (Isoniazid, Refampicin & Pyrazinamide)
but showed no improvement. Upon follow-up with a frank case of exposure
to mother with active Tuberculosis, untreated, non-compliant to treatment, a
fourth drug of Ethambutol was added to the re-started Triple Anti-Koch’s but
still not much clinical improvement.
PHYSICIAN: DR. CATHERINE MENDOZA,
PEDIATRICIAN
PATIENT: ROBERT N., 5 YO MALE (2009, WCMC)
REGIMEN:
TF ADVANCED 1 CAPSULE 2 X A DAY
Triple Anti-Koch’s Regimen
48. TESTIMONY ON PRIMARY COMPLEX
This is a multi drug resistant TB case
(MDRTB)*
treated with Triple Anti-Koch’s regimen (Isoniazid, Refampicin & Pyrazinamide)
but showed no improvement. Upon follow-up with a frank case of exposure
to mother with active Tuberculosis, untreated, non-compliant to treatment, a
fourth drug of Ethambutol was added to the re-started Triple Anti-Koch’s but
still not much clinical improvement.
PHYSICIAN: DR. CATHERINE MENDOZA, PEDIATRICIAN
PATIENT: ROBERT N., 5 YO MALE (2009, WCMC)
REGIMEN:
TF ADVANCED 1 CAPSULE 2 X A DAY
Triple Anti-Koch’s Regimen
RESULT : remarkable clinical improvement:
weight gain, resolution of pulmonary symptoms,
good appetite after 3 weeks.
Note: *more than 200 SIMILAR SUCCESSFUL CASES ABOVE with FULL
49. TESTIMONY ON ADULT TB CASE
& NO HISTORY OF CHILDBIRTH
PHYSICIAN: DR. CATHERINE MENDOZA, PEDIATRICIAN
PATIENT: SUSAN O., 33 YO FEMALE (2009, WCMC)
REGIMEN:
TF ADVANCED 2 CAPSULE 3 X A DAY
Triple Anti-Koch’s Regimen
50. TESTIMONY ON ADULT TB CASE
& NO HISTORY OF CHILDBIRTH
PHYSICIAN: DR. CATHERINE MENDOZA, PEDIATRICIAN
PATIENT: SUSAN O., 33 YO FEMALE (2009, WCMC)
REGIMEN:
TF ADVANCED 2 CAPSULE 3 X A DAY
Triple Anti-Koch’s Regimen
RESULT : remarkable clinical improvement:
resolution of pulmonary symptoms after 3 weeks.
BONUS: In 2010, patient discovered she’s pregnant
and gave birth to a healthy baby girl after 6 years of
waiting.
51. TESTIMONY ON STAGE 4 DENGUE
HEMORRAHGIC FEVER WITH
MUCUCUTANEOS
AND RENAL (KIDNEY) BLEEDING
PLATELET COUNT ONLY: 16,000
PHYSICIAN: DR. CATHERINE MENDOZA, PEDIATRICIAN
JULIET S., 21 YO FEMALE (2008, ST. LUKES HOSP.)
REGIMEN:
TF PLUS 5 CAPSULES 3 X A DAY
52. TESTIMONY ON STAGE 4 DENGUE
HEMORRAHGIC FEVER WITH MUCUCUTANEOS
AND RENAL (KIDNEY) BLEEDING
PLATELET COUNT ONLY: 16,000
PHYSICIAN: DR. CATHERINE MENDOZA, PEDIATRICIAN
JULIET S., 21 YO FEMALE (2008, ST. LUKES HOSP.)
REGIMEN:
TF PLUS 5 CAPSULES 3 X A DAY
RESULT: PLATELET COUNT IN 3 DAYS = 300,000
Note: More than 200 SUCCESSFUL DENGUE CASES with FULL RECOVERY UN
DR CATHERINE MENDOZA todate and counting!
53. In its Methodoligical Letter (Moscow 2004), The
Ministry of Health and Social
Development of the Russian Federation
published the following:
"Acquired Immunorehabilitation Syndrome (AIDS) is one of the most
serious problems confronting medicine. For HIV patients immune
modulation therapy (i.e. the restoration of normal immune function) is
aimed at altered immune mechanisms and at the pathogenic agent(s).
The results of studies conducted showed that TRANSFER FACTOR (TF)
PLUS treatment significantly improved the immune status of HIV patients.
The product also proved useful in other aspects of therapy as for example
the level of circulating immune complexes (CIC) decreased to normal values
in 50% of patients receiving TF PLUS."
PLUS
54. Transfer Factors in HIV-Infected Patients
Granitov V.M., Karbysheva N.V., Sultanov L.V., McCausland C., Oganova E., The Altay State Medical University; The Altay
Regional Center for Prophylaxis and Treatment of AIDS, Russian Federation
INTRODUCTION: Included in this study were 25 HIV-infected patients
(20 male and 5 female), ages 19 to 56 (15 patients ages 21-25). Individuals were classified
according to V.I. Pokrovsky’s classification (1989) for HIV-infection. Eight (8) patients
were diagnosed to have stage 2B, thirteen (13) patients were stage 2C, three (3) patients
were stage 3A and one (1) was stage 3B. Infection periods were as follows: nine (9)
patients were infected 1 year ago, four (4) were 2 years ago, four (4) were three years
ago, six (6) were 5 years ago and two (2) were 6 years ago.
OBJECTIVE: The purpose of this study is to serve as an initial trial in evaluating the
effects of enhanced transfer factors supplementation on HIV-infected patients.
METHODOLOGY: The experimental group (15 patients), who did not receive
antiretroviral or immuno-correcting therapy, received enhanced transfer factors provided
by 4Life Research, USA. They were administered one capsule twice a day for 7 days. The
control group (10 patients) consisted of HIV-infected patients taking cycloferon in the
following dosage schedule: 1st, 2nd, 4th, 6th, 8th, 10th, 12th and 14th days. Before
treatment and 7 to 10 days after the treatment an evaluation was carried out to access
the immune status of the patient groups and to determine cytokine (interleukin 1b (IL-
1b), tumor necrosis factor (TNF-a) and g-interferon (IFN-g) levels.
55. Transfer Factors in HIV-Infected Patients
Granitov V.M., Karbysheva N.V., Sultanov L.V., McCausland C., Oganova E., The Altay State Medical University; The Altay
Regional Center for Prophylaxis and Treatment of AIDS, Russian Federation
RESULTS: In the experimental group, it was found that after treatment with enhanced
transfer factors there was an increase of lymphocytes in 13 patients, an in crease of CD3
cells in 15 patients, an increase of CD4 cells in 14 patients and an increase in CD8 cells in
12 patients. Immuno-regulating index (IRI) persisted on the same level in 3 patients was
increased in 10 patients and decreased in 7 patients. IgG was reduced in 16 patients and
IgM was within normal limits in all patients. An increase of IL-1b and IFN-7 was noted in
all patients treated with transfer factors. Circulating Immune Complex (CIC)
levels dropped to normal levels in 10 of the patients. In the control
group an increase of lymphocytes was noted in only 3 patients. A decrease of CD3, CD4
and CD8 cells was noted in 6 patients. IRI persisted on the same level or decreased. CIC
levels dropped to normal in 3 patients, increased in 6 patients, there was no change in 1
patient. The occurrence of increases and decreases of IgG were equal.
CONCLUSION: We conclude that transfer factors therapy considerably
improves the immune status of HIV-infected patients and can be
recommended in combating the pathogenesis of the disease. Further
studies are needed to determine optimal therapy, the necessity to repeat courses of the
treatment and the frequency of therapy needed.
56. IX NATIONAL
CONGRESS OF
DIETOLOGISTS AND
NUTRIOLOGISTS
THAT TOOK PLACE
IN MOSCOW, RUSSIA
DECEMBER 3-5,2005
57. Transfer Factor is a Modifier of Biological Age
A.G. Chizhov, V.A. Santalova Russian People’s Friendship University, Moscow
INTRODUCTION: There is a close link between the decrease of functional activity of
the immune system and aging. Thus, we decided to study immunomodulators to determine
to what extent they may affect biological age indices. A new immune theory of aging
(V.I.Dontsov, V.N. Krut’ko, 2002) points to the role of specific T-lymphocytes
subpopulations in sustaining a certain level of normal cellular growth in the body and dwells
on the importance of their functional decrease having
a strong impact on aging. Stimulation of the function of these cells by Transfer Factor (TF),
an immunomodulator produced by 4Life, USA, seemed a plausible method of “treating
aging”.
OBJECTIVE: The evaluation of the role TF in the process of aging is at the basis of this
study.
METHODOLOGY: Twelve (12) men aged 55-73 were included in the study. A dose of
300 mg. of the TF product was given daily with meals 5 times a week for 6 weeks.
Biological age was determined using the “АPK” method (“Diagnostics of aging: biological
age” (National gerontology center, Moscow)). The following biomarkers were used for
making the determinations: AP (arterial pressure), pulse wave velocity, VC (vital pulmonary
capacity), static balance, Shtange’s test, adaptation testing, body mass, left hand strength,
Shulte’s test, Veksler’s test, neuromuscular test, hearing frequency threshold and the SAN’s
questionnaire. The functional activities of body systems were evaluated by means of
Nakatani’s electropuncture diagnostics.
58. Transfer Factor is a Modifier of Biological Age
A.G. Chizhov, V.A. Santalova Russian People’s Friendship University, Moscow
RESULTS: Chronological age of the group was 63.5±0.7. Before the
use of TF the biological age of the group differed from chronological by
-4.2 ±0.6 years. The majority of men demonstrated a decrease in the
functional activity of endocrine and of immune systems’ as well as
hyperfunction of the liver and of urinary bladder and hypofunction
pancreatic.
CONCLUSION: The study showed that initially disturbed body
system functions were significantly normalized. After the course of TF
treatment the difference between biological and chronological age was
(-8.2) ±0.5 years(p<0.05),>
rejuvenation effect of 4 years in just 6 weeks!
82. TESTIMONY ON SEVERE ATOPIC
DERMATITIS
(A.K.A. SKIN ASTHMA FOR 22 YEARS)
MAYA C., 22 YO, FEMALE (2008)
REGIMEN: TF TRI-FACTOR
DOSAGE: 2 CAPS 2 X A DAY
Others: Skin Ointment
83. TESTIMONY ON SEVERE ATOPIC
DERMATITIS
(A.K.A. SKIN ASTHMA FOR 22 YEARS)
MAYA C., 22 YO, FEMALE (2008)
REGIMEN: TF TRI-FACTOR
DOSAGE: 2 CAPS 2 X A DAY
Others: Skin Ointment
RESULT IN 21 DAYS: CLEAR SKIN
85. TESTIMONY ON FERTILITY
(10 WOMEN AGES: 24-33
NO HISTORY OF CHILDBIRTH )
PHYSICIAN: DR. DELICIAFLOR PEREA, OB-GYNE
REGIMEN:
TF TRI-FACTOR 2 CAPS 3 X A DAY
OTHER MEDICINES
86. TESTIMONY ON FERTILITY
(10 WOMEN AGES: 24-33
NO HISTORY OF CHILDBIRTH )
PHYSICIAN: DR. DELICIAFLOR PEREA, OB-GYNE
REGIMEN:
TF TRI-FACTOR 2 CAPS 3 X A DAY
OTHER MEDICINES
RESULTS: PREGNANCY IN 2 MONTHS
87. TESTIMONY ON MILD ALZHEIMERS
DISEASE
(ON DIAPERS FOR TWO YEARS
UNAWARE AND NO CONTROL OF
BOWEL MOVEMENT)
AMY T.., 76 YO FEMALE (2009, ST. LUKES)
REGIMEN:
TF ADVANCE 2 CAPS 3 X A DAY
TF RIOVIDA 30 ML 3 X A DAY
88. TESTIMONY ON MILD ALZHEIMERS
DISEASE
(ON DIAPERS FOR TWO YEARS
UNAWARE AND NO CONTROL OF BOWEL
MOVEMENT)
AMY T.., 76 YO FEMALE (2009, ST. LUKES)
REGIMEN:
TF ADVANCE 2 CAPS 3 X A DAY
TF RIOVIDA 30 ML 3 X A DAY
RESULTS: IN 3 WEEKS, SIGNALS FOR BOWEL
MOVEMENT AND IS GETTING AWARE OF HER
SURROUNDINGS & GETTING JEALOUS AGAIN.
TODAY, SHE’S WELL & TOURING IN THE U.S.
89. TESTIMONY ON EPILEPTIC
WOMAN WITH 6-8 SEIZURES A DAY
(SOMETIMES JUMPS OUT OF THE
WINDOW)
JANICE M., 24 YO FEMALE (OCT 2011,
PALAWAN)
REGIMEN:
TF PLUS 2 CAPS A DAY
RESULTS:
90. TESTIMONY ON EPILEPTIC
WOMAN WITH 6-8 SEIZURES A DAY
(SOMETIMES JUMPS OUT OF THE
WINDOW)
JANICE M., 24 YO FEMALE (OCT 2011,
PALAWAN)
REGIMEN:
TF PLUS 2 CAPS A DAY
RESULTS: IN 4 DAYS, SEIZURES STOPPED
COMPLETELY
91. TESTIMONY ON KIDNEY STONES
(Size: 1.2cmx0.40cm)
BENG P., 61 YO FEMALE (2011, MAKATI)
REGIMEN:
TF RIOVIDA 80ML 3 X A DAY FOR 4 DAYS
RESULT:
92. TESTIMONY ON KIDNEY STONES
(Size: 1.2cmx0.40cm)
BENG P., 61 YO FEMALE (2011, MAKATI)
REGIMEN:
TF RIOVIDA 80ML 3 X A DAY FOR 4 DAYS
RESULT: IN 10 DAYS, A KIDNEY STONE CAME
OUT NATURALLY
93.
94. TESTIMONY ON ERECTILE
DYSFUNCTION
(15 YEARS E.D., AND RECENTLY
UNDERWENT BY-PASS OPERATION)
PHYSICIAN: DR. DELICIAFLOR PEREA, OB-GYNE
PATIENT: MANUEL D., 73 YO MALE (2009)
REGIMEN:
TF TRI-FACTOR 2 CAPS 3 X A DAY
TF CARDIO 1 CAP 3 X A DAY
95. TESTIMONY ON ERECTILE
DYSFUNCTION
(15 YEARS E.D., AND RECENTLY
UNDERWENT BY-PASS OPERATION)
PHYSICIAN: DR. DELICIAFLOR PEREA, OB-GYNE
PATIENT: MANUEL D., 73 YO MALE (2009)
REGIMEN:
TF TRI-FACTOR 2 CAPS 3 X A DAY
TF CARDIO 1 CAP 3 X A DAY
RESULTS: NORMALCY IN 1 MONTH
96. TESTIMONY ON STROKE
(HALF-BODY PARALYZED, CAN’T
TALK)
ANGELITO M., 46 YO, MALE (2010)
REGIMEN:
TF CARDIO: 3 CAPS 3 X A DAY
TF RIOVIDA: 30 ML 2X A DAY
97. TESTIMONY ON STROKE
(HALF-BODY PARALYZED, CAN’T
TALK)
ANGELITO M., 46 YO, MALE (2010)
REGIMEN:
TF CARDIO: 3 CAPS 3 X A DAY
TF RIOVIDA: 30 ML 2X A DAY
RESULT: RECOVERED ON 3RD DAY
98. TESTIMONY ON KIDNEY FAILURE
(EXTREMELY WEAK, BEDRIDDEN, CAN
NOT URINATE, ON DIALYSIS 3X A
WEEK)
FR. JOE GARDUCE, 65 YO (PALAWAN)
REGIMEN:
TF CARDIO: 2 CAPS A DAY
TF TRI-FACTOR : 6 CAP 3X A DAY
DIET: NO MEAT ALL VEGETABLES & STEAMED FISH
RESULT:
99. TESTIMONY ON KIDNEY FAILURE
(EXTREMELY WEAK, BEDRIDDEN, CAN
NOT URINATE, ON DIALYSIS 3X A
WEEK)
FR. JOE GARDUCE, 65 YO (PALAWAN)
REGIMEN:
TF CARDIO: 2 CAPS A DAY
TF TRI-FACTOR : 6 CAP 3X A DAY
DIET: NO MEAT ALL VEGETABLES & STEAMED FISH
RESULT: FULL OF ENERGY IN 2 WEEKS, &
ON 2ND MONTH: CAN NOW SAY MASS 3 X A DAY
AND NOW PLAYS BASKETBALL EVERYDAY.
100. TESTIMONY ON 4 CLOGS IN THE
HEART ARTERIES DUE FOR
ANGIOPLASTY
(HOSPITALIZED DUE FOR HEART
OPERATION COSTING PHP1.2 MILLION)
EDWARD D., 56 YO (ILOILO)
REGIMEN:
TF CARDIO: 2 CAPS 3X A DAY
TF RIOVIDA : 30ML 3X A DAY
RESULT:
101. TESTIMONY ON 4 CLOGS IN THE
HEART ARTERIES DUE FOR
ANGIOPLASTY
(HOSPITALIZED DUE FOR HEART
OPERATION 56 YO (ILOILO)
EDWARD D., COSTING PHP1.2 MILLION)
REGIMEN:
TF CARDIO: 2 CAPS 3X A DAY
TF RIOVIDA : 30ML 3X A DAY
RESULT: “LABTEST SHOWED NO MORE CLOGS
ON THE 3 DAY. SURGERY WAS CANCELLED,
RD
MY BROTHER WAS DISCHARGED FROM THE
HOSPITAL AND WENT STRAIGHT TO
WORK” - MSGR. JOSE DELFIN, PALAWAN
103. Core
Products
No Contra-indication
No Contra-indication
• No Overdose
No Overdose
• No Side Effects
No Side Effects
104. Transfer Factor “Advance”
Tri-Factor Formula
Contains Pure Transfer Factor
Contains Pure Transfer Factor
Recommended for:
Recommended for:
•Auto Immune Dysfunction
•Auto Immune Dysfunction
•For Prevention
•For Prevention
•Safe for infants
•Safe for infants 4LIFE TF TRI-
FACTOR ADVANCE
ITEM# 170024070
BFAD# FR-63738
HALAL CERTIFIED Islamic Food &
Nutrition Council of America
PATENT# 6,468,534
105. Transfer Factor Plus
Tri-Factor Formula + Herbs
Tri Factor Advance + the most powerful
Tri Factor Advance + the most powerful
proprietary blend of herbs that more
proprietary blend of herbs that more
than double the boosting power of Tri-
than double the boosting power of Tri-
Factor “Advance”.
Factor “Advance”.
4LIFE TF TRI-
Recommended for:
Recommended for: FACTOR PLUS
•Infections
ITEM# 170024075
•Infections BFAD# FR-56143
HALAL CERTIFIED Islamic Food &
•Chronic ailmentTerminal Diseases
•Chronic ailmentTerminal Diseases
Nutrition Council of America
PATENT# 6,468,534 & 6,866,868
Ingredients:
Ingredients:
Beta Glucans, Maitake, Shitake Mushroom, Aloe
Beta Glucans, Maitake, Shitake Mushroom, Aloe
Vera Mannans, Olive leaf extract, Cordyceps, IP6
Vera Mannans, Olive leaf extract, Cordyceps, IP6
110. 4LifeTransfer Factors Factor Glucoach
Targeted
Transfer
4LIFE TF GLUCOACH
ITEM# 170029001
BFAD# FR-56461
HALAL CERTIFIED Islamic Food & Nutrition
✴ For those individuals with levels already in
Council of America
PATENT# 6,468,534 & 6,866,868
the normal range,.
110
116. home
Is Transfer Factor safe for
Q:
children?
A: YES!
117. home
Why do 4Life Transfer Factor
Q: products have disclaimers
on its labels?
A:
Because it is required by the Bureau
of Food & Drugs (BFAD).
118. home
Can I take Transfer Factor
Q: even if I’m currently taking
pharmaceutical drugs?
A: YES!
You can take Transfer Factor as an
adjunct to your existing medicine.
119. home
Can we recommend Transfer
Factor
Q: to people taking immuno
suppressants?
A: NO
They are the only people who are not
recommended to take Transfer Factor.
120. home
I am allergic to milk and eggs,
Q: can I take Transfer Factor?
A: YES!
Allergy is an auto-immune
dysfunction.
COLOSTRUM
1. Water
2. Vitamins / Minerals
3. Protein
4. Fat
5. Carbohydrates (Lactose)
6. Immunoglobins
7. Slight Growth Hormones
8. Transfer Factors
121. home
Q: How much product should I take?
A:
Healthy: Daily recommended value
Sick: 2X Daily recommended value
Chronic Ailment: 3X Daily recommended value
Terminally ill: 4X to 5X Daily recommended value
122. home
Can you overdose on
Q: Transfer Factor Products?
A: NO!
Base on clinical study at 2,000X of
the Daily Recommended Value or at
6,000 capsules level of toxicity is ZERO.
